Edgemond James's Form 4 filing
United Therapeutics Corp (UTHR) · filed Apr 24, 2026
- Accession no.
- 0001636178-26-000012
- Filed
- Apr 24, 2026
- Trade date
- Apr 22-23, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.72M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edgemond JamesCIK 0001636178 | Officer (CFO AND TREASURER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Common Stock | MOption exerciseAcquired | +10,000 | $135.42 | +$1,354,200 | 28,876 | Direct | |
| Apr 23, 2026 | Common Stock | SSaleDisposed | −280 | $569.63F2 | −$159,496.4 | 28,596 | Direct | |
| Apr 23, 2026 | Common Stock | SSaleDisposed | −1,079 | $570.82F3 | −$615,914.78 | 27,517 | Direct | |
| Apr 23, 2026 | Common Stock | SSaleDisposed | −3,325 | $571.64F4 | −$1,900,703 | 24,192 | Direct | |
| Apr 23, 2026 | Common Stock | SSaleDisposed | −3,976 | $572.66F5 | −$2,276,896.16 | 20,216 | Direct | |
| Apr 23, 2026 | Common Stock | SSaleDisposed | −321 | $573.51F6 | −$184,096.71 | 19,895 | Direct | |
| Apr 23, 2026 | Common Stock | SSaleDisposed | −535 | $574.79F7 | −$307,512.65 | 19,360 | Direct | |
| Apr 22, 2026 | Common Stock | SSaleDisposed | −364 | $575.85F8 | −$209,609.4 | 18,996 | Direct | |
| Apr 23, 2026 | Common Stock | SSaleDisposed | −120 | $576.62F9 | −$69,194.4 | 18,876 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 62,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $569.19 to $570.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $570.19 to $571.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $571.19 to $572.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $572.19 to $573.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $573.22 to $574.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $574.28 to $575.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $575.30 to $576.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $576.45 to $576.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.